Pharmacokinetic Considerations in Determining the Terminal Elimination Half-Lives of Bisphosphonates

By Kenneth C. Lasseter  

Clinical Drug Investigation, Vol. 25, Iss. 2, 2005-01 ,pp. : 107-114

Adis International

Access to resources Recommend Favorite

Elimination Half-Lives of Selected Polychlorinated Dibenzodioxins and Dibenzofurans in Breast-Fed Human Infants

By Leung Hon-Wing   Kerger Brent   Paustenbach Dennis  

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 6, 2006-04 ,pp. : 437-443

Taylor & Francis Ltd

Access to resources Recommend Favorite

Application of Simple Mathematical Expressions to Relate Half-Lives of Drugs in Mice to Those in Humans

By  

Drug Metabolism Letters, Vol. 1, Iss. 2, 2007-01 ,pp. : 127-129

Bentham Science Publishers

Access to resources Recommend Favorite

Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives: Analysis of Data from Three Randomized, Single-Dose, Pharmacokinetic Studies

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 613-623

Adis International

Access to resources Recommend Favorite

Intermittent drug dosing intervals guided by the operational multiple dosing half lives for predictable plasma accumulation and fluctuation

By Grover Anita   Benet Leslie  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 3, 2011-06 ,pp. : 369-383

Springer Publishing Company

Access to resources Recommend Favorite